General information of patients and Adverse Events and Treatment during PTIP

Pathology revealed that all patients had an adenocarcinoma, 10 cases of carcinoma of gastric cardia, 1 case of gastric body carcinoma and 1 case of gastric sinus carcinoma. Seven cases (7/12) were in stage III and five cases (6/12) in stage IV.  The patients with carcinoma of gastric cardia had dysphagia in different degrees, 2 cases of grade 4 (16.7%), 2 cases of grade 3 (16.7%). 3 cases had gastrointestinal bleeding.

Details and features are shown in Table 1.Note：G: gender; Y: year; OX,: Oxaliplatin；RET: Retitrose; LHA: left hepatic artery; RHA: right hepatic artery; DYS: Dysphagia；HYP: hypertension; VHC: viral hepatitis C; VHB: viral hepatitis B; LGA: left gastric artery; RGA: right gastric artery; RGPA: right gastroepiploic artery; AP: abdominal pain; AD: abdominal distention; CTH: chemotherapyComplications, adverse effects, and management There were no serious adverse events such as gastric perforation and gastrointestinal bleeding during the peri-interventional treatment period (PITP).